Pulse Audition: Leveraging DNN-Based Speech Enhancement for Improved Communication in Assistive Listening Devices

This talk explores the evolution of Deep Neural Network (DNN) based approaches in speech enhancement and source separation. Beginning with a historical overview, it traces the progression from traditional methods to the current state-of-the-art techniques. Emphasizing the persistent challenge of speech intelligibility in noisy environments, the discussion transitions to the contemporary issue of inadequate performance in conventional hearing aids. The approach adopted by Pulse Audition of integrating DNN-based technologies into hearing assistance systems is then highlighted, presenting a promising avenue for significantly enhancing communication for individuals with hearing impairments.

Manuel Pariente's Bio (Co-Founder Pulse Audition)

Manuel is an AI Engineer with a passionate mission: to ensure that people suffering from hearing loss can maintain vital social connections. He is the co-founder and CEO of Pulse Audition, a pioneering startup that develops intelligent hearing glasses designed to enhance speech intelligibility in challenging, noisy environments. Before devoting his time to Pulse Audition, Manuel studied Physics, Cognitive Sciences, Artificial Intelligence and Signal Processing at Ecole Normale Supérieure and IRCAM, and conducted a PhD in AI-based speech enhancement at INRIA (France). Manuel's overarching vision is to employ technology as a force for societal betterment. By using innovation to address the pressing issue of hearing loss and its social consequences, he embodies a commitment to keeping our society well-connected, fostering inclusivity, and enriching the lives of countless individuals.

Thibaud Moufle-Milot (Co-founder Pulse Audition)

Thibaud is a health tech enthusiast, he completed a dual curriculum in Health Engineering and Business Management from the University of Pharmacy of Grenoble and Grenoble École de Management (France). He has experience working as a research engineer at INSERM, CNRS, and CEA, and as a clinical project manager and business developer in setting up clinical protocols for medical devices. Thibaud also worked as a consultant in a regulatory consulting firm, where he gained experience in quality management systems, ISO standards, non-clinical and clinical strategy, and procedures for obtaining CE markings in Europe and De Novo / 510(k) markings with the FDA.